Mangrove Partners IM, LLC 13D and 13G filings for Mereo BioPharma Group plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 09:16 am Sale | 2025-09-30 | 13G | Mereo BioPharma Group plc MREO | Mangrove Partners IM, LLC | 38,952,900 4.900% | -4,811,565 (-10.99%) | Filing |
| 2024-02-14 12:36 pm Purchase | 2023-12-31 | 13G | Mereo BioPharma Group plc MREO | Mangrove Partners IM, LLC | 43,764,465 6.240% | 43,764,465 (New Position) | Filing |